Objective: The HIV epidemic has carved contrasting trajectories around the world with sub-Saharan Africa (SSA) being most affected. We hypothesized that mean HIV-1 plasma RNA viral loads are higher in SSA than other areas, and that these elevated levels may contribute to the scale of epidemics in this region.
Introduction
Sub-Saharan Africa (SSA) continues to be the region hardest hit by the HIV pandemic. It is home to 70% of the world's estimated 2.7 million new HIV infections in 2010, as well as 68% of the estimated 34 million persons living with HIV [1] . Whereas in other regions HIV transmission is concentrated in populations with a identifiable high-risk sexual or injecting-drug behaviors, in SSA HIV infection is prevalent in the general population with low levels of reported sexual risk behaviors [2] . Multiple behavioral, ecological, and biological host factors and viral characteristics may have contributed to the striking contrast between the HIV epidemic trajectory in SSA and other regions [2] , such as differences in concurrency patterns and sexual networks [3] , coinfections that drive higher HIV-1 plasma RNA viral load [4] , and sub-type-specific viral dynamics [5] . Yet the interplay of factors contributing to disproportionately high HIV prevalence in the general population in SSA, and not in other regions, remains poorly understood.
HIV-1 viral load is a principal determinant of heterosexual HIV transmission [6, 7] . Ample experimental and observational studies have shown that suppression of HIV viral load leads to large reduction in HIV transmission [8] . Decreases in community viral load have been associated with reductions in HIV incidence [9] . Each one log 10 copies/ml increase in viral load has been found to more than double the per coital-act probability of HIV transmission [10, 11] .
In light of the link between HIV infectiousness and viral load level, we hypothesized that a specific biological cofactor contributed to the contrasting HIV epidemic trajectories between SSA and other regions; specifically we hypothesized that community level HIV-1 viral load in SSA is higher than in other regions, and is substantially higher to the extent that it can drive divergent epidemic trajectories between SSA and other regions. We examined this hypothesis by addressing two specific research questions: Are viral load levels higher in SSA compared to other regions? Can these higher viral loads explain, in part, the fulminant HIV transmission dynamics observed in SSA, in contrast to other regions?
Methods

Participants and settings
We obtained the mean HIV-1 plasma RNA viral load from prospective cohorts of HIV-infected, antiretroviral therapy (ART)-naive study participants across seven geographic regions ( Table 1 and Supplemental Digital Content (SuppDC ) Table S3 .1, http://links.lww.com/QAD/ A283). Overall, the studies included 15 cohorts of men, 10 cohorts of pregnant women, 14 cohorts of nonpregnant women, five cohorts of women with unknown pregnancy status, and a total of 71 668 viral load measurements (SuppDC Sections 1 and 3, http://links.lww.com/QAD/ A283). Data from each cohort consisted of the mean viral load for participants in the following CD4 categories: below 200, 200-349, 350-499, and at least 500 cells/ml by sex and pregnancy status. In addition, for each study, we captured the geographic location, viral load assay used, predominant subtype in the region, and intervention description. We excluded studies in which the intervention had a potential impact on viral load, such as acyclovir, or used only baseline enrolment data.
Statistical methods
Mean log 10 viral load was modeled using a linear regression model with the following predictors: indicators 982 AIDS 2013, Vol 27 No 6 
Mathematical modeling methods
We assessed the epidemiological implications of the regional differences in viral load by constructing and analyzing a deterministic compartmental mathematical model describing HIV epidemic expansion in a representative SSA population; that of Kisumu, Kenya (SuppDC Section 4, http://links.lww.com/QAD/ A283). The model calculates the proportion of incident HIV infections that are directly attributable to the viral load effect, or population-attributable fraction (PAF). It stratifies the population into compartments according to HIV sero-status and stage of HIV infection, sexual-risk activity group, and exposure to a biological cofactor that heightens viral load. This cofactor modulates HIV infectiousness according to the empirical relationship between viral load and HIV per-coital transmission probability as observed initially by Quinn et al. [10] in Uganda, and affirmed recently in the Partners in Prevention study [11] . Table 2 summarizes the key assumptions in our model and a detailed description of the model and its parameterization can be found in SuppDC Section 4, http://links.lww.com/QAD/A283.
Recognizing that multiple uncontrolled variables, such as type of viral load assay and changes in sexual activity due to co-infection-associated morbidities, may affect viral load or its effect on HIVepidemic trajectory, we reported conservative predictions for the impact of the viral load effect on HIV epidemic expansion and conducted multiple sensitivity and uncertainty analyses on the model predictions (SuppDC Sections 4.4.3-5 and 4.5, http://links.lww.com/QAD/A283). We assumed a 20% smaller increase in mean viral load in SSA relative to North America than emerged from our database analyses (0.46 log 10 rather than 0.58 log 10 ; the results assuming the full 0.58 log 10 increase can be found in SuppDC Section 4.4.2, http://links.lww.com/QAD/A283). We also assumed a 20% sexual-activity reduction with the heightened viral load to account for potential illnessassociated abstinence during co-infections that increase HIV-1 viral load. The latter is a conservative assumption because malaria morbidity, a frequent co-infection in SSA, generally lasts for less than 10% of the period of heightened viral load due to malaria [4, [13] [14] [15] [16] . Moreover, only a very small fraction of the prevalent herpes simplex virus type 2 (HSV-2) seropositive persons suffer from clinically apparent ulcers, and even among those, HSV-2 reactivations are predominately asymptomatic [17, 18] . Of note, the assumed 20% reduction in sexual activity reflects a reduction throughout HIV infection natural history and not merely a reduction in sexual activity during a transient episode of a specific coinfection, which biases our model results towards a lower impact of the viral load effect. Finally, although coinfection-induced viral load does not appear to accelerate HIV disease progression to AIDS or death in SSA [19, 20] , we accounted for this potential effect in the model to assess whether such mechanism could influence our predictions (SuppDC Sections 4.4.3 and 4.5, http:// links.lww.com/QAD/A283).
Results
There was striking heterogeneity in mean viral load (Table 1) . Compared with North America, viral load levels were significantly higher in SSA (Fig. 1 ). The estimated mean log 10 viral load was 0.29 higher [95% Table 2 . Key assumptions of our mathematical model assessing the epidemiological impact of the heightened HIV-1 plasma RNA viral load in sub-Saharan Africa. a
Assumption Parameter value Source
Rate ratio increase in HIV-1 coital transmission probability per one-log 10 rise in HIV-1 plasma viral load 2.45 [10, 11] Logarithmic increase in HIV-1 plasma viral load level in sub-Saharan Africa relative to North America 0.46 Statistical analyses of the viral load database with 20% reduction in estimated regional differences to account for potential systematic biases in comparing viral load data across regions Reduction in coital frequency associated with the heightened HIV-1 plasma viral load
20%
Conservative assumption a Detailed description of the model and its biological and behavioral parameters can be found in SuppDC Section 4, http://links.lww.com/QAD/ A283. confidence interval (CI) 0.11-0.47] in West Africa, 0.71 higher (95% CI 0.48-0.93) in East Africa, and 0.74 higher (95% CI 0.55-0.92) in Southern Africa, excluding the South African study sites ( SuppDC Table S3 .2, http://links.lww.com/QAD/A283). The estimated mean log 10 viral load was modestly, but significantly, higher in Asia than in North America [0.14 higher (95% CI 0.03-0.26)], but no difference was seen in mean log 10 viral load between Europe or South America and North America (P ¼ 0.66 and 0.49, respectively).
Compared to North America, the mean difference in viral load across the three resource-poor sub-regions of SSA, East, West, and Southern Africa, with each subregion weighted by its HIV-infected population size, is 0.58 log 10 (95% CI 0.45-0.71). South Africa, with its substantially lower burden of tropical co-infections that drive higher HIV-1 viral load (see Discussion section), particularly malaria [21] , and better access to care than much of SSA, was considered separately. Indeed, mean viral load in South Africa was lower than that in North America. However, this anomaly may be largely due to the use of the bDNA viral load assay for mainly subtype C infections which, in this laboratory, has been associated with consistently lower viral load results (SuppDC Figure  S3 .2, http://links.lww.com/QAD/A283) [22] . When data from this laboratory are excluded, mean viral load borders on being significantly higher in South Africa than in North America [0.19 log 10 (95% CI À0.02 to 0.39) versus À0.33 log 10 (95% CI À0.49 to À0.18) with inclusion of the bDNA assay results]. SuppDC Section 3.5, http://links.lww.com/QAD/A283 includes a discussion and further analysis of the data from South Africa. Applying our mathematical model to assess the epidemiological implications of such differences in viral load in a setting representative of a hyper-endemic HIVepidemic in SSA (Kisumu, Kenya), the viral load effect substantially augmented HIV epidemic expansion (Fig. 2a) . The viral load effect contributed an excess HIV prevalence (prevalence with no viral load effect subtracted from prevalence with the viral load effect) of 2.9% (95% CI 1.4-3.6%) at the epidemic peak, and 2.7% (95% CI 1.5-3.2%) at the endemic equilibrium (CI estimated using the CI of the mean viral load in resource-poor SSA). The viral load effect fuelled an excess HIV incidence rate (incidence rate with no viral load effect subtracted from incidence rate with the viral load effect) of 0.69 (95% CI 0.39-1.04) per 100 person-years at the epidemic peak, and 0.48 (95% CI 0.27-0.56) per 100 person-years at endemic equilibrium. The proportion of incident HIV infections that is directly attributable to the viral load effect (PAF) increased with time, reaching 14.4% (95% CI 7.7-20.5%) at the epidemic peak in the mid to late 1990s (Fig. 2b) . The proportion of cumulative incident HIV infections that is directly attributable to the viral load effect (PAF cum ) is 13.9% by 2010.
Our calculations show that the relative impact of the viral load effect is largest in the majority of the population exhibiting the lowest sexual risk behavior, the general population. HIV prevalence in the low-risk group increased by 22.5%, whereas that in the higher risk groups increased by 4.4-11.1% ( SuppDC Table S4 We performed a broad range of sensitivity analyses to the magnitude of the heightened viral load, reduction in sexual activity associated with the heightened viral load (the heightened viral load could be due to co-infections that lead to co-morbidities as discussed in Methods and Discussion sections), and enhancement of the rate of disease progression associated with the heightened viral load. We found that a reduction in coital frequency with the elevated viral load greater than 34% is needed to balance the increase in infectiousness due to the viral load effect, whereas any increase in viral load greater than 0.25 log 10 would result in considerable population-level impact for this effect. The strong effect was robust to variations in the model parameters, including both the behavioral and biological inputs used to parameterize the model. As expected, our model predictions are primarily sensitive to the exact magnitudes of both the heightened viral load and the assumed level of sexual activity reduction associated with it. The lower the reduction in sexual activity, the higher is the impact of the viral load effect.
Discussion
We found substantial regional differences in viral load with SSA having about four times the viral load levels found elsewhere. The highest viral load levels were seen in Southern and East Africa. Modeling the impact of the elevated viral load in a representative population, Kisumu, Kenya, we demonstrated that the elevated viral load in SSA could be a central driver of the massive HIV epidemics that erupted in this part of the world. The viral load effect is particularly important driver of HIV transmission among the general population and may explain, in part, the general population HIV epidemics that uniquely characterize this region. The robustness of our results to multiple sensitivity and uncertainty analyses points to a potentially substantial role for this biological cofactor in shaping HIV epidemic trajectories in SSA and warrants further investigation. The higher regional viral load in SSA poses a question about the causes of such elevated viral load levels. We suspect that the high burden of infectious diseases beyond HIV in SSA, particularly malaria, tuberculosis, HSV-2, helminthes, and other tropical diseases [20] , may have caused to a large extent the higher viral load in SSA. Mounting epidemiological and laboratory evidence suggests that these co-infections induce transient, but substantial increases in HIV-1 viral load, due to enhanced HIV replication associated with the immune response (see SuppDC Section 2, http://links.lww.com/QAD/A283 for description of evidence). A recent systematic review and meta-analysis found that acute malaria increases HIV-1 viral load by 0Á67 log 10 (95% CI 0.15, 1.19) , active tuberculosis by 0.40 log 10 (95% CI 0.13-0.67), and HSV-2 infection by 0Á18 log 10 (95% CI 0.01, 0.34) [23] . Furthermore, high levels of serum immune activation markers have been found in African populations compared to those in industrialized countries [24] [25] [26] , possibly reflecting extended exposure to a range of pathogens. Together, the comparatively high burden of infectious diseases in SSA, and the links among coinfections, immune activation and increased HIV replication, suggest that viral load may be higher in this region than elsewhere, and that immune activation due to co-infections may be an important causal mechanism.
The first work to explore the impact on HIV epidemic trajectory of a co-infection that increases HIV-1 viral load, for the case of malaria, suggested a small, but tangible effect in fuelling HIV spread [4] . But the impact of a single co-infection on HIV transmission may be relatively limited, whereas the combined effects of multiple recurrent or persistent co-infections could potentially result in considerable population-level impact.
The transient effect of one co-infection increasing viral load may not be discernible at the population level, but the cumulative effect of multiple potentially overlapping co-infections on raising the viral load, throughout the course of HIV infection, may be substantial as schematized in Fig. 3 [27] . Such effect would alter the natural history of HIV infection for the individual and consequently the epidemic trajectory for the community.
Another reason, in addition to co-infections, that may contribute to explaining the elevated mean viral loads in SSA is virus subtype. Emerging data suggest that persons infected with HIV-1 subtype C infection, the dominant type in SSA particularly in Southern Africa, may maintain high viral loads even after acute infection [28] .
Our approach assumes a log-linear relationship between HIV-1 viral load and HIV per coital-act transmission probability, based primarily on empirical evidence from cohort studies of sero-discordant couples [10, 11] . These studies may under or over-estimate the relationship between viral load and risk of transmission due to selection bias such as the selection of more 'resistant' couples in the recruitment of discordant partnerships with high viral load-infected individuals. A linear relationship between viral load and risk of transmission, assuming implicitly, for example, a simplistic concept for the establishment of the infection in terms of clonal expansion of a single infecting virion, would imply a stronger effect for the higher viral load on transmission, and more differential epidemiologic impact as a consequence of the differences in community viral load.
To our knowledge, the database we assembled in this study of summary measures of more than 70 000 viral load measurements from cohorts representing every major region of the globe, is the most extensive ever analyzed to assess the regional viral load differences and their impact Fig. 3 . Potential role of co-infections in causing higher community HIV-1 plasma RNA viral load (VL). Schematic diagram of the potential role of the high co-infection disease burden in sub-Saharan Africa (SSA) in increasing mean HIV-1 VL (diagram not to scale). At low co-infection prevalence, such as in resource-rich settings, the natural course of HIV-1 VL resembles that in yellow. In SSA, repeated co-infections resulting in bursts of viremia (in red), may lead, at the population level, to a higher mean HIV-1 VL over the course of HIV-1 infection, and greater aggregate person-time above the threshold HIV-1 VL for HIV-1 transmission. This figure is an adaptation from that in Cohen and Pilcher [27] . on HIV transmission. However, there are limitations to these exploratory analyses. We used heterogeneous datasets from studies not designed to investigate this effect. Our hypothesis of higher-community viral load in SSA was examined using regional viral load data measured on participants recruited for different reasons (Table S3 .1). The recruitment strategies could, in principle, be a source of selection bias where the viral load data were measured on individuals who may not necessarily represent the community of HIV-infected persons, and this may confound the assessment of the regional viral load differences. Of note, however, this vast amount of viral load data was collected from participants who were recruited using diverse recruitment strategies. The diversity of the modes of recruitment suggests a minimal bias in recruitment of persons who are more likely to have higher (or lower) viral load in one region as opposed to another.
The widest difference in viral load between SSA and developed settings was observed in the CD4 at least 500 category (Table 1) , a category that potentially could encompass samples including persons within acute infection. The observed differences in viral load could accordingly reflect differences in the distribution of persons across HIV natural history stages. However, all except one of the viral load studies in this analysis have targeted recruitment of HIV sero-prevalent participants, suggesting minimal contribution of acute infection. Beyond acute infection, we stratified our analysis in four CD4 categories and this should implicitly, at least in part, correct for potential differences between the regions in the distribution of persons across HIV natural history stages.
Our ecological analysis did not control for viral load assay type which could potentially affect the observed regional viral load differences. Although we were not able to control for viral load assay, PCR-based assays were used in both North America and SSA. Viral load assays would have to provide consistently lower absolute viral load readings in North America and Europe, and higher readings in SSA, for this difference in viral load to be seen. Historically, the opposite trend has been observed; commercially available RNA tests are generally optimized to detect subtype B, which predominates in North America and Europe, and are frequently suboptimal in detecting HIV-1 subtypes found in other parts of the world [29] . Furthermore, despite the heterogeneity of assays used within North America and Europe, mean viral loads were similar. Another limitation of our database is the small number of viral load cohorts from Asia and South America, where only a single country is represented from each region. Finally, pregnancy data were incomplete in five cohorts.
Nevertheless, our study provides a tantalizing 'smoking gun', suggesting both substantially higher viral loads in SSA compared to other regions, and a potentially profound viral load effect on HIV infectiousness and epidemic trajectory. This is despite conservative assumptions in the mathematical model for the magnitude of the heightened viral load and the potential impact of coinfection-associated morbidities on sexual activity.
Several lines of evidence support our findings. The viral load differences we found ($ 0.3 to 0.7 log 10 ) are similar to those observed earlier (0.7 log 10 ) in comparing a cohort of 49 Malawians to a cohort of 61 US and Swiss HIV-positive patients matched by CD4 cell count [30] . Yet, existing evidence suggests that African descent among those residing in North America and Europe is associated with lower, not higher, viral load [31, 32] . Therefore, it is likely that ecological factors, such as frequently recurrent or persistent co-infections and HIV-1 sub-type, rather than host biology factors, explain these regional viral load differences. Recent data further indicate that individuals living in areas of high malaria prevalence have more than twice the odds of being HIVpositive than individuals living in areas with low malaria prevalence [odds ratio (OR) of 2.24, 95% CI 1.62-3.12 for men and 2.44, 95% CI 1.85-3.21 for women] [33] .
Additional lines of evidence support our thesis of higher HIV infectiousness per coital act in SSA compared to other regions. A recent systematic review and metaanalysis found HIV transmission probability per coital act in low-income countries (predominantly SSA countries) to be six times that in high-income settings [34] . The viral load regional differences identified here of 0.58 log 10 implies that the per-coital transmission probability in SSA is only 1.68 times that in North America and Europe ( SuppDC Table S4 .2, http://links.lww.com/QAD/ A283); smaller than that observed in this meta-analysis [34] . This suggests that other factors may also contribute to the higher HIV infectiousness in SSA. The recent landmark HPTN 52 clinical trial found four-fold higher HIV sero-conversion rate among the sero-discordant partnerships in the African sites compared to the non-African sites [8] , further supporting higher HIV infectiousness in SSA.
One of the truly remarkable research advances of the past 2 years was the demonstration of the very high efficacy of ART in reducing HIV transmission [8, 35] . This outcome attests to the critical role of viral load in driving HIV epidemics. Observational studies and intervention trials designed specifically to elucidate the role of co-infections in HIV infectiousness and epidemic trajectory -such as the on-going trial evaluating the impact of helminthes treatment on HIV-1 viral load in Kenya [36] -are essential. They will determine whether aggressive prevention and treatment of selected, persistent or frequently recurrent, co-infections should be included in randomized controlled trials of combination HIV prevention packages, and in HIV prevention programs and policy recommendations. As we are learning from trials evaluating HSV-2 treatment for HIV prevention [37, 38] , this may require development of new regimens that target the biological mechanisms underpinning these interactions.
A potential role for co-infections in the exceptionally fulminant spread of HIV in Africa is of great interest because these infections offer feasible intervention points with co-benefits that lie at the intersection of HIV prevention and other major health programs. Until we can assure immediate and sustained access to ART for all people diagnosed with HIV infection, complementary strategies will be essential. Addressing co-infections potentially may offer such a complementary strategy for the control of HIV in SSA.
